Flavin-containing monooxygenases: mutations, disease and drug response

被引:113
作者
Phillips, Ian R. [2 ]
Shephard, Elizabeth A. [1 ]
机构
[1] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
[2] Univ London, Sch Biol & Chem Sci, London E1 4NS, England
关键词
D O I
10.1016/j.tips.2008.03.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Flavin-containing monooxygenases (FMOs) metabolize numerous foreign chemicals, including drugs, pesticides and dietary components and, thus, mediate interactions between humans and their chemical environment. We describe the mechanism of action of FMOs and insights gained from the structure of yeast FMO. We then concentrate on the three FMOs (FMOs 1, 2 and 3) that are most important for metabolism of foreign chemicals in humans, focusing on the role of the FMOs and their genetic variants in disease and drug response. Loss-of-function mutations of FMO3 cause the disorder trimethylaminuria. More common variants that decrease enzyme activity are associated with increased drug efficacy. Most humans are homozygous for a nonsense mutation that inactivates FMO2. But a substantial proportion of sub-Saharan Africans express functional FMO2 and, thus, are predicted to respond differently to drugs and other foreign chemicals.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 76 条
[1]   Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3) [J].
Allerston, Charles K. ;
Shimizu, Makiko ;
Fujieda, Masaki ;
Shephard, Elizabeth A. ;
Yamazaki, Hiroshi ;
Phillips, Ian R. .
PHARMACOGENETICS AND GENOMICS, 2007, 17 (10) :827-839
[2]  
Brunelle A, 1997, DRUG METAB DISPOS, V25, P1001
[3]  
Cashman JR, 2001, DRUG METAB DISPOS, V29, P1629
[4]   The implications of polymorphisms in mammalian flavin-containing monoloxygenases in drug discovery and development [J].
Cashman, JR .
DRUG DISCOVERY TODAY, 2004, 9 (13) :574-581
[5]   Human flavin-containing monooxygenases [J].
Cashman, JR ;
Zhang, J .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :65-100
[6]  
Cashman JR, 1999, J PHARMACOL EXP THER, V288, P1251
[7]   Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria [J].
Cashman, JR ;
Camp, K ;
Fakharzadeh, SS ;
Fennessey, PV ;
Hines, RN ;
Mamer, OA ;
Mitchell, SC ;
Preti, G ;
Schlenk, D ;
Smith, RL ;
Tjoa, SS ;
Williams, DE ;
Yannicelli, S .
CURRENT DRUG METABOLISM, 2003, 4 (02) :151-170
[8]   Increased incidence of FMO1 gene single nucleotide polymorphisms in sporadic amyotrophic lateral sclerosis [J].
Cereda, Cristina ;
Gabanti, Elisa ;
Corato, Manuel ;
De Silvestri, Annalisa ;
Alimontv, Dario ;
Cova, Emanuela ;
Malaspina, Andrea ;
Ceroni, Mauro .
AMYOTROPHIC LATERAL SCLEROSIS, 2006, 7 (04) :227-234
[9]   Diagnosis and management of trimethylaminuria (FMO3 deficiency) in children [J].
Chalmers, RA ;
Bain, MD ;
Michelakakis, H ;
Zschocke, J ;
Iles, RA .
JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (01) :162-172
[10]  
DOLPHIN C, 1991, J BIOL CHEM, V266, P12379